Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

In a study published in 2023, young and old Caenorhabditis elegans worms treated with the drug – which is normally used to ...

A recent study has found a possible link between a commonly prescribed high blood pressure drug and an increased risk of ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced positive topline results from its pivotal Launch-HTN Phase 3 and ...

Doctors have traditionally advised patients to take blood pressure medication in the morning because blood pressure tends to ...

Discover 7 tips to lower high blood pressure naturally, from the DASH diet to stress management techniques that can help you ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

Findings from a pair of studies in tough-to-treat hypertension establish Mineralys’ drug as a “derisked, almost-commercial ...

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood ...

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...